362 related articles for article (PubMed ID: 25014748)
1. Design and synthesis of new of 3-(benzo[d]isoxazol-3-yl)-1-substituted pyrrolidine-2, 5-dione derivatives as anticonvulsants.
Malik S; Ahuja P; Sahu K; Khan SA
Eur J Med Chem; 2014 Sep; 84():42-50. PubMed ID: 25014748
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and anticonvulsant activity of new 1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-diones.
Kamiński K; Rzepka S; Obniska J
Bioorg Med Chem Lett; 2011 Oct; 21(19):5800-3. PubMed ID: 21875804
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticonvulsant activity of new N-Mannich bases derived from 3-(2-fluorophenyl)- and 3-(2-bromophenyl)-pyrrolidine-2,5-diones. Part II.
Obniska J; Rzepka S; Kamiński K
Bioorg Med Chem; 2012 Aug; 20(15):4872-80. PubMed ID: 22717240
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, physicochemical, and anticonvulsant properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and its 3-methyl analog.
Rybka S; Obniska J; Rapacz A; Filipek B; Kamiński K
Arch Pharm (Weinheim); 2014 Oct; 347(10):768-76. PubMed ID: 25139813
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of (5-amino-1, 2, 4-triazin-6-yl)(2-(benzo[d] isoxazol-3-yl) pyrrolidin-1-yl)methanone derivatives as sodium channel blocker and anticonvulsant agents.
Malik S; Khan SA
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):505-16. PubMed ID: 23914929
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticonvulsant properties of new mannich bases derived from 3,3-disubstituted pyrrolidine-2,5-diones. Part IV.
Obniska J; Chlebek I; Kamiński K
Arch Pharm (Weinheim); 2012 Sep; 345(9):713-22. PubMed ID: 22674811
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticonvulsant activity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 3-phenyl-pyrrolidine-2,5-dione.
Obniska J; Kaminski K; Skrzynska D; Pichor J
Eur J Med Chem; 2009 May; 44(5):2224-33. PubMed ID: 18603334
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives.
Kamiński K; Rapacz A; Łuszczki JJ; Latacz G; Obniska J; Kieć-Kononowicz K; Filipek B
Bioorg Med Chem; 2015 May; 23(10):2548-61. PubMed ID: 25868743
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, physicochemical and anticonvulsant properties of new N-[(4-arylpiperazin-1-yl)alkyl]-3-phenyl- and 3-(3-methyl-phenyl)-pyrrolidine-2,5-diones.
Obniska J; Chlebek I; Pichór J; Kopytko M; Kamiński K
Acta Pol Pharm; 2009; 66(6):639-47. PubMed ID: 20050528
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticonvulsant properties of new N-Mannich bases derived from 3,3-diphenyl- and 3-ethyl-3-methyl-pyrrolidine-2,5-diones. Part III.
Obniska J; Chlebek I; Kamiński K; Karolak-Wojciechowska J
Arch Pharm (Weinheim); 2013 Jan; 346(1):71-82. PubMed ID: 23180594
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological properties of new N-Mannich bases derived from 3-methyl-3-phenyl- and 3,3-dimethyl-succinimides. Part V.
Kamiński K; Obniska J; Chlebek I; Liana P; Pękala E
Eur J Med Chem; 2013 Aug; 66():12-21. PubMed ID: 23777899
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and anticonvulsant activity of N-phenylamino derivatives of 3,3-dialkyl-pyrrolidine-2,5-diones and hexahydro-isoindole-1,3-diones.
Kamiński K; Obniska J
Bioorg Med Chem; 2008 May; 16(9):4921-31. PubMed ID: 18375131
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticonvulsant properties of new Mannich bases derived from 3-aryl-pyrrolidine-2,5-diones. Part 1.
Obniska J; Kopytko M; Zagórska A; Chlebek I; Kamiński K
Arch Pharm (Weinheim); 2010 Jun; 343(6):333-41. PubMed ID: 20379970
[TBL] [Abstract][Full Text] [Related]
14. New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]pyrrolidine-2,5-diones.
Kamiński K; Zagaja M; Rapacz A; Łuszczki JJ; Andres-Mach M; Abram M; Obniska J
Bioorg Med Chem; 2016 Feb; 24(4):606-18. PubMed ID: 26746343
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological activity of new amides derived from 3-methyl-3-phenyl-2,5-dioxo-pyrrolidin-1-yl-acetic acid.
Obniska J; Rapacz A; Rybka S; Powroźnik B; Pękala E; Filipek B; Żmudzki P; Kamiński K
Eur J Med Chem; 2015 Sep; 102():14-25. PubMed ID: 26241874
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, anticonvulsant properties, and SAR analysis of differently substituted pyrrolidine-2,5-diones and piperidine-2,6-diones.
Kamiński K; Wiklik B; Obniska J
Arch Pharm (Weinheim); 2014 Nov; 347(11):840-52. PubMed ID: 25196991
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and anticonvulsant activity of new hybrid compounds derived from 2-(2,5-dioxopyrrolidin-1-yl)propanamides and 2-(2,5-dioxopyrrolidin-1-yl)butanamides.
Kamiński K; Zagaja M; Łuszczki JJ; Rapacz A; Andres-Mach M; Latacz G; Kieć-Kononowicz K
J Med Chem; 2015 Jul; 58(13):5274-86. PubMed ID: 26052884
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of anticonvulsant properties of new N-Mannich bases derived from 3-(1-phenylethyl)- and 3-benzyl-pyrrolidine-2,5-dione.
Rybka S; Obniska J; Rapacz A; Furgała A; Filipek B; Żmudzki P
Bioorg Med Chem Lett; 2016 May; 26(9):2147-51. PubMed ID: 27032334
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and anticonvulsant properties of new N-Mannich bases derived from 3-phenylpyrrolidine-2,5-diones.
Kamiński K; Obniska J; Chlebek I; Wiklik B; Rzepka S
Bioorg Med Chem; 2013 Nov; 21(21):6821-30. PubMed ID: 23993970
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives.
He X; Zhong M; Zhang T; Wu W; Wu Z; Yang J; Xiao Y; Pan Y; Qiu G; Hu X
Eur J Med Chem; 2010 Dec; 45(12):5870-7. PubMed ID: 20947222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
